Treatment of Reactive Arthritis with Biological Agents.
- Published in:
- Current Rheumatology Reports, 2024, v. 26, n. 12, p. 450, doi. 10.1007/s11926-024-01165-6
- By:
- Publication type:
- Article
Works matching IS 15233774 AND DT 2024 AND VI 26 AND IP 12
Results: 5
1
2
Telemedicine for the Care of Patients with Idiopathic Inflammatory Myopathies: Experience, Insights and Future Directions from the International Myositis Assessment and Clinical Studies Telemedicine Scientific Interest Group.
- Published in:
- 2024
- By:
- Publication type:
- Letter
3
Recent Updates on the Pathogenesis of Inflammatory Myopathies.
- Published in:
- Current Rheumatology Reports, 2024, v. 26, n. 12, p. 421, doi. 10.1007/s11926-024-01164-7
- By:
- Publication type:
- Article
4
How to Distinguish Non-Inflammatory from Inflammatory Pain in RA?
- Published in:
- Current Rheumatology Reports, 2024, v. 26, n. 12, p. 403, doi. 10.1007/s11926-024-01159-4
- By:
- Publication type:
- Article
5
Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): Update on Prevalence, Risk Factors, Pathogenesis, and Therapy.
- Published in:
- Current Rheumatology Reports, 2024, v. 26, n. 12, p. 431, doi. 10.1007/s11926-024-01155-8
- By:
- Publication type:
- Article